# X4 Pharmaceuticals (XFOR) — Earnings

XFOR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/xfor/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$3.47 |
| EPS estimate | −$3.94 |
| EPS surprise | +11.88% |
| Revenue surprise | +21.82% |
| Revenue | $2.0M |
| Revenue estimate | $1.6M |
| Reported | Aug 8, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1501697/000162828025039327/xfor-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 8, 2025 | −$3.94 | −$3.47 | 11.88% | $1.6M | $2.0M |
| Q1 2025 | May 1, 2025 | −$3.55 | $0.04 | 101.13% | $11.6M | $28.8M |
| Q4 2024 | Mar 25, 2025 | −$5.28 | −$6.00 | -13.64% | $1.1M | $1.4M |
| Q3 2024 | Nov 13, 2024 | −$5.14 | −$5.40 | -5.00% | $1.7M | $560,000.00 |
| Q2 2024 | Aug 8, 2024 | −$0.21 | $13.50 | 6399.58% | $15.3M | $563,000.00 |
| Q1 2024 | May 7, 2024 | −$4.63 | −$7.80 | -68.52% | — | — |
| Q4 2023 | Mar 21, 2024 | −$4.37 | −$3.00 | 31.37% | — | — |
| Q3 2023 | Nov 9, 2023 | −$4.47 | −$0.30 | 93.28% | — | — |
| Q2 2023 | Aug 10, 2023 | −$4.87 | −$9.90 | -103.42% | — | — |
| Q1 2023 | May 4, 2023 | −$6.38 | −$4.80 | 24.71% | — | — |
| Q4 2022 | Mar 21, 2023 | −$8.10 | −$8.70 | -7.41% | — | — |
| Q3 2022 | Nov 3, 2022 | −$9.00 | −$7.80 | 13.33% | — | — |
| Q2 2022 | Aug 4, 2022 | −$19.00 | −$18.00 | 5.26% | — | — |
| Q1 2022 | May 12, 2022 | −$18.04 | −$21.60 | -19.71% | $128,571.00 | — |
| Q4 2021 | Mar 17, 2022 | −$20.23 | −$37.20 | -83.90% | — | — |
| Q3 2021 | Nov 4, 2021 | −$21.45 | −$22.80 | -6.29% | — | — |
| Q2 2021 | Aug 3, 2021 | −$22.16 | −$22.20 | -0.17% | — | — |
| Q1 2021 | May 6, 2021 | −$25.15 | −$39.00 | -55.07% | — | — |
| Q4 2020 | Mar 4, 2021 | −$27.09 | −$27.30 | -0.77% | — | — |
| Q3 2020 | Nov 5, 2020 | −$22.67 | −$26.10 | -15.14% | — | — |

## Frequently Asked Questions

### When did X4 Pharmaceuticals (XFOR) last report earnings?

X4 Pharmaceuticals last reported on Aug 8, 2025, covering fiscal Q2 2025.

### Did XFOR beat earnings estimates?

Yes. X4 Pharmaceuticals reported EPS of −$3.47 for Q2 2025 against a −$3.94 estimate — a 11.88% beat.

### How much revenue did XFOR report last quarter?

X4 Pharmaceuticals reported $2.0M in revenue for Q2 2025, against a consensus estimate of $1.6M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).